Angioedema Terminated Phase 2 Trials for Mepolizumab (DB06612)

Also known as: Angioedema reactions / Angio edema / Angioedemas / Angioneurotic edema / Angioedema (morphologic abnormality) / Angioneurotic oedema / Oedema angioneurotic / Quincke's edema / Angioedema (disorder) / Edema angioneurotic / Angioedema and urticaria / Angio-edema / Oedema Quincke's / Quincke's oedema / Giant urticaria / Edema Quincke's / Urticaria giant / Giant urticaria (disorder) / Giant hives / Hives giant

IndicationStatusPhase
DBCOND0013604 (Angioedema)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04128371Mepolizumab in Episodic Angioedema With EosinophiliaTreatment